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ABSTRACT 
Chemical  and  radioautographic  analysis of  the  small  intestine of  mice  injected  intra- 
peritoneally with puromycin revealed an immediate decrease of precursor incorporation 
into DNA and protein and a  delayed decrease of precursor incorporation into RNA.  In 
addition to this decrease of precursor incorporation, damage to the crypt cells, but not to 
the cells of the villus of the small intestine, was observed.  Further examination of other 
dividing cells  (spleen)  and nondividing cells  (liver and heart)  of these  mice showed  again 
that only cells of actively dividing tissues were damaged. The metabolic inhibitors actino- 
mycin D, cytosine arabinoside, actidione, and puromycin aminonucleoside  were used in an 
attempt to clarify the mechanism of cell damage by puromycin. The results showed  that 
there was no clear correlation between cell necrosis and the pattern of inhibition of syn- 
thesis of DNA, RNA, or protein. 
INTRODUCTION 
The  antibiotic  puromycin  is  known  to  inhibit 
protein  synthesis  by  blocking  the  transfer  of 
amino  acids  from  aminoacyl-sRNA to  thc  pep- 
tide  chain  (26).  In  addition,  puromycin  blocks 
the  incorporation of  precursors  into  both  RNA 
and DNA  (15,  24).  The data of Licbcrman and 
coworkers (24) indicate further that the decreased 
incorporation of precursors into both protein and 
DNA  is  almost  complete  within  1  hr  after  the 
addition of puromycin to primary cultures of rab- 
bit kidney cells. 
We have chosen the small intestine of mouse to 
assay in vivo the effect of puromycin on continu- 
ously dividing cells.  Our rcsults indicate a  rapid 
and marked inhibition of precursor incorporation 
into DNA  and protein and  a  more  gradual de- 
crease  in  precursor  incorporation  into  RNA, 
thus confirming thc results of Gottlieb et al.  (15) 
and Liebcrman et el.  (24).  Microscope cxamina- 
tion  of  sections  taken  from  the  small  intestine, 
spleen,  heart,  and  liver  of  puromycin-treated 
mice revealed necrosis only among cells known to 
be  actively  dividing,  namely crypt  cells  of  the 
small intestine and cells  of the  germinal centers 
of the spleen and lymphoid tissue, whereas cells of 
the other tissues examined were not visibly dam- 
aged. Acfidione, whose action is similar to that of 
puromycin, and other antibiotics and antimetab- 
olites  acting on  a  narrower  range  of metabolic 
processes  were  used  in  an  attempt  to  correlate 
the  production of necrosis in dividing cells  with 
the  pattern  of inhibition of  metabolic  processes 
or with the phase of the cell cycle (29). 
MATERIALS  AND  METHODS 
Strain A male mice, 4 to 6 months old and weighing 
an average  of 30 g  each,  were  used.  The following 
antibiotics  or  antimetabolites were  injected  intra- 
13 peritoneally :  puromycin  hydrochioride  and  the 
aminonucleoside  of  puromycin  (Nutritional  Bio- 
chemicals  Corporation,  Cleveland,  Ohio)  dissolved 
in  saline-phosphate  buffer  (14);  actinomycin  D  (a 
gift  of  Merck,  Sharp  and  Dohme,  West  Point, 
Pennsylvania)  dissolved  in  saline;  actidione  (cyclo- 
heximide,  a  gift of Dr.  Savage of The Upjohn Co., 
Kalamazoo,  Michigan)  suspended  in  sterile  water; 
and  cytosine  arabinoside  (gift  of  Dr.  A.  E.  Oster- 
berg, NIH  Cancer Chemotherapy Center,  Bethesda, 
Maryland,  and Dr.  Savage of The Upjohn Co.)  dis- 
solved  or  suspended  in sterile water.  Controls were 
injected with appropriate solvents.  All radioisotopes 
(New  England  Nuclear  Corp.,  Boston,  Massachu- 
setts) were injected subcutaneously (28) and had the 
following  specific  activities:  thymidine-methyl-H  3, 
6.7  c/mmole;  DL-leucine-4,5  hydrochloride-H  a, 
5.0  c/mmole, L-leucine-C  14,  uniformly  labeled,  233 
mc/mmole;  uridine-H  3,  3.0  c/mmole;  uridine-2- 
C a4,  30  mc/mmole,  and  cytidine-H 3,  2.0  c/mmole. 
All other chemicals were  of reagent grade. 
The  animals  were  killed  by  cervical  dislocation, 
and approximately 500 to 800 mg of small intestine, 
beginning 5  cm from the squamocolumnar junction 
of the stomach,  were  removed.  A  small segment  of 
intestine from the  most  proximal  portion was  fixed 
for radioautography  in calcium formalin or in Car- 
noy's  solution.  Intestinal  contents  were  removed 
from the remaining portion which was weighed and 
homogenized with ice cold water in a  Potter-Elveh- 
jem homogenizer with a  Teflon pestle. 
NUCLEIC  ACID  DETERMINATION:  Aliquots of 
homogenate were  extracted by the method of Scott, 
Fraccastoro,  and  Taft  (35),  and  three  fractions, 
acid-soluble,  RNA,  and  DNA,  were  obtained.  The 
amounts  of  DNA  and  RNA  were  determined  by 
ultraviolet  spectrophotometry.  The  method  of 
Scott,  Fraccastoro,  and  Taft  (35)  was  used  for  the 
determination  of  DNA,  and  the  two-wavelength 
method of Tsanev and Markov  (38)  and Fleck  and 
Munro  (1 l)  was  used  for  determining  RNA.  The 
radioactivity  of  each  fraction  was  determined  by 
liquid  scintillation  counting  (l).  Specific  activities 
were calculated as counts per minute per milligram 
of DNA or RNA. 
DETERMINATION  OF  INCORPORATION  INTO 
PROTEIN:  The  amount  of  leucine  incorporated 
into proteins was  determined by dissolving the resi- 
due,  remaining  after  extracting  nucleic  acids  with 
the  above  method  (35),  in  1  N  KOH  for  1  hr  at 
60°C.  One-tenth mi of the digest was used for liquid 
scintillation counting.  The limits of accuracy of this 
procedure were determined in previous studies  (17). 
In  tissues  of animals  injected with  radioactive  leu- 
cine,  80%  of  the  acid-insoluble  radioactivity  was 
found in the 1 N KOH fraction, While the remaining 
radioactivity  was  found  in  the  RNA  (17%)  and 
DNA  (3%)  fractions.  Since leucine  is  incorporated 
only into  proteins  (1),  the  radioactivity in the  l  N 
KOH  fraction represents 80~o  of the total radioac- 
tivity  incorporated  into  proteins.  In  the  present 
paper,  the  results  of leucine  incorporation  are  ex- 
pressed as counts per minute per 100 rag (wet weight) 
of small intestine. 
RADIOAUTOORAPHY  AND  HISTOLOGY:  The 
fixed tissues were embedded in paraffin, from which 
3  to  5  #  sections  were  cut.  Radioautographs  were 
prepared  by  the  dip  coating  method  of Joftes  and 
Warren  (20),  with  Eastman Kodak  NTB  emulsion. 
Radloautographs,  after  exposure  and  photographic 
processing,  and  routine  sections  were  stained  with 
Maycr's  hematoxylin and  eosin.  The  percentage  of 
labeled cells and the mean grain count were  deter- 
mined  as  previously  described  (1).  Thc  pcrcentagc 
of  damaged  cells  was  determined  after  200  crypt 
cells  were  counted  in  at least  four  segments  of the 
small intestinc of each mouse. 
RESULTS 
Puromycin  (2.5  nag  per  mouse)  was  injected  in- 
traperitoneally every hour for a  total of four injec- 
tions  (10  mg  per  mouse)  starting  at  zero  time. 
Thymidine-H  3,  leucine-H  3,  and  uridine-H  a  were 
injected  subcutaneously,  30  min  before  killing, 
at  times  beginning  immediately  after  the  first 
injection  of  puromycin.  Fig.  1  shows  the  effect 
of puromycin  treatment  on  the  incorporation  of 
thymidine-H  s  into  DNA,  leucine-H  ~ into protein, 
and  uridine-H  3  into  RNA,  of  small  intestine. 
Thymidine  incorporation  into  DNA,  expressed 
in  counts  per  minute  per  milligram  of  DNA, 
was  46%  of control  values  30  min  after  the  first 
injection of puromycin.  Subsequently,  incorpora- 
tion dropped  to  13 %  of control values at 90  min 
and  remained  slightly  below  this  level  for  the 
remainder  of  the  experiment.  Incorporation  of 
leucine-H  3 into protein of the small intestine  (see 
Materials  and  Methods)  decreased  to  35%  of 
control values at 30 rain after the first injection of 
puromycin and remained at the same level at  120 
min.  The incorporation of uridine-H  a into RNA, 
expressed  in  counts  per  minute  per  milligram  of 
RNA,  was  actually  increased  75  rain  after  the 
first injection of puromycin,  confirming the find- 
ings of Hamilton  (16),  but,  by  the  second  hour, 
it  decreased  to  about  50%  of  control  values. 
Radioautography of the small intestine confirmed 
the results of the chemical  analyses,  but in  addi- 
tion  disclosed  severe  damage  of  crypt  cells  of 
animals  receiving  three  and  four  injections  of 
puromycin.  The  experiments  were  extended  to 
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FmlmE 1  Effect of pm'omyein on incorporation of thymidine into DNA (Q---Q), leueine into protein 
(O--O), and uridine into RNA (O'" 0). Arrows on the abscissa indicate intraperiteneal puromycin in- 
jections (2.5 mg per mouse). All isotopes weir injected subcutaneously 30 min before killing. Each point 
represents the mean of 3 to 5 animals. Vertical bars represent ranges. 
determine:  (a)  whether  the  lesion  could  be  re- 
produced  with a  similar dose of a  different lot of 
puromycin,  and  (b)  whether  the  crypt  damage 
could be induced with fewer injections by leaving a 
longer time interval  between  the  last  injection of 
puromycin  and  killing.  The  results  are  shown  in 
Table  I.  The upper  half of the Table shows that 
crypt damage  was produced  by a  different lot of 
puromycin.  The lower group of values shows that 
two  injections,  which  had  produced  fragmenta- 
tion  of occasional  nuclei  in  the  original  experi- 
ment,  produced  extensive damage  when  a  longer 
time  interval  was  left  between  the  last injection 
and killing. The data in this Table indicated that 
at  least  two  injections and  an  interval  of 3  to  4 
hr  were  necessary  for  crypt  damage  to  become 
visible. 
Illustrations of crypt damage are shown in Figs. 
2 to 5.  Normally columnar  cells became cuboidal 
in  extensively damaged  crypts.  The  cell  borders 
became indistinct and  the cytoplasm increasingly 
basophilic.  Many of the cells lost definite nuclear 
membranes.  Many  nuclei  were  replaced  by  a 
thin  rim  of  basophilic  material  surrounding  a 
clear  area  in  which  were  pyknotic  nuclear  frag- 
ments.  There  was  no  apparent  damage  to  cells 
of  the  villi.  In  these  experiments  sections  were 
also  taken  from  liver,  heart,  and  spleen,  The 
TABLE  I 
Effect  of  Puromycin  on  Histologic  Appearance  of 
Crypts  of  Small  Intestine  of Mice* 
No.  of puromycin  Time  between first  Per cent necrosis of 
injections  injection  and  death  crypt ceils 
hr 
1  0.5  0 
2  1.5  <5 
3  2.5  65-85 
4  3.5  >85 
1  4.0  <5 
2  5.0  65-85 
3  6.0  >85 
4  7.0  >85 
* Puromycin  2.5  mg per  intraperitoneal  injection 
every hour.  The first four  groups of animals  were 
killed 30  rain  after  the  last  puromycin  injection, 
and  the  others,  4  hr  after  the  last  puromycin 
injection. 
germinal  centers of the  spleen,  in which  the per- 
centage  of  cells  in  DNA  synthesis  is  relatively 
high  (5),  showed  numerous  necrotic  cells.  No 
damage  was found  in livers and  hearts,  tissues in 
which  the  number  of cells  in  DNA  synthesis  is 
very small (25)• 
R.  D.  ESTENSEN  AND  R,  BASERGA  Nee'rode  of Cryl)t CeUs  15 lq'mVRE ~  Slight to moderate crypt damage in small intestine of mouse given one injection of puromyein 
(5.0 mg) intraperitoneally, and killed 6 hr later. Hematoxylin and eosin.  X  100. 
FlovaE 8  Higher magnification of Fig. £. Hematoxylin and eosin.  X  ~50. 
16  THE  JOUIaNAL OF  CELL BIOLOGY • VOLUME 80,  1966 FIGURE 4  Extensive damage  in crypts  of small intestine of  mouse given puromycin  (~.5  mg)  intra- 
peritoneally hourly for 4 hr and killed 30 rain after the final injection. Hematoxylin and eosin. )<  100. 
FiotmE 5  Higher magnification of Fig. 4. Hematoxylin and eosin. )< ~50. 
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Effect of Dose and Time of Injection of Puromycin on Incorporation of Leucine-H  3 into Protein* 
Incorporation 
Interval between  of leucine-Ha 
No.  of  last injection  into  protein: 
puromycin  Total  of puromyc~n and  per cent  of  Percentage  of 
Tissue  injections  dose  death  controls  necrotic  cells:~ 
mg  hr 
Small intestine  1  2.5  1  33  0 
1  2.5  3  104  <5 
2  5.0  3  126  58-85 
3  7.5  3  130  >85 
4  10.0  3  46  >85 
Small intestine  1  1.25  6  143  0 
1  2.5  6  134  0 
1  5.0  6  104  28-38 
Liver  1  2.5  1  29  0 
1  2.5  3  73  0 
2  5.0  3  77  0 
3  7.5  3  61  0 
4  10.0  3  24  0 
Heart  1  2.5  1  34  0 
1  2.5  3  83  0 
2  5.0  3  63  0 
3  7.5  3  75  0 
4  l0.0  3  33  0 
* Puromycin,  2.5  mg  per  mouse,  was  injected  intraperitoneally  at  1  hr  intervals. 
Leucine-H  3 was  injected  subcutaneously  1  hr  prior  to  death. 
Cells  in this column  are crypt cells for small intestine; hepatocytes for liver; and 
myocardial  cells for heart. There were at least 3  mice for each group. 
Table  II  illustrates the  effect of puromycin on 
the incorporation of leucine  into  protein of small 
intestine and other organs when the time interval 
between the last injection and killing is increased. 
Cell  damage  regularly  appeared  in  the  crypts 
of the small intestine. However,  3  hr after the last 
injection  of  puromycin,  the  incorporation  of 
leucine was at control levels in the small intestine 
while remaining below control levels in both liver 
and heart. The Table also indicates that the lowest 
single  dose  which  produced  irreversible  cell 
damage was 5  mg per mouse.  It should be noted 
that,  immediately after a  single injection of puro- 
mycin,  the  incorporation  of leucine  into  protein 
was equally inhibited in small intestine, liver, and 
heart. Apparently,  there was  a  reversal in the in- 
hibition of protein  synthesis by  puromycin  when 
3  or  more  hours were  allowed  to  elapse  between 
the  last injection of puromycin  and  death.  How- 
ever, inhibition of protein synthesis became seem- 
ingly irreversible after four  injections of puromy- 
tin. 
The  results,  thus  far,  may  be  summarized  as 
follows: puromycin injected hourly in the amount 
of 2.5 mg per mouse produced a  prompt inhibition 
of  protein  synthesis  and  DNA  synthesis  and  a 
delayed  inhibition of RNA  synthesis in  the small 
intestine.  In  addition,  two  injections,  1  hr  apart, 
were  sufficient to  destroy  the crypts  of the  small 
intestine and  to  produce  necrosis in  other  tissues 
where  cells  in  DNA  synthesis  are  numerous.  In 
the  experiments  to  be  described,  we  have  at- 
tempted  to  answer  two  questions  posed  by  these 
results: 
1.  In  which  phase  of  the  cell  cycle  did  this 
dose of puromycin act? 
2.  By what mechanism did puromycin produce 
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tion is prominent? 
Effect  of  Puromyein  on  the  Cell  Cycle  of 
Crypt Cells of the Small Intestine 
The cell cycle (29)  is defined as the time period 
between  the  midpoint  of  mitosis  in  the  parent 
cell  and  the  midpoint  of mitosis in  the daughter 
cell.  This  cycle  is  divided  into  four  phases:  Gt, 
the period  between completion of mitosis and  the 
beginning  of DNA  synthesis;  the  phase  of DNA 
replication  or  S  phase;  G2,  the  period  between 
completion  of  DNA  synthesis  and  mitosis;  and 
mitosis  or  M.  According  to  Lesher  et  al.  (23) 
the  cell cycle  of  the  crypt  cells of the  small  in- 
testine  of  mice  of  this  age  can  be  subdivided 
TABLE  III 
Effect of Puromyvin on the G2 Phase of the Cell Cycle 




dine~Hs  Labeled  Per cent labeled 
and  ceils per  mitoses, mean  Mitotic 
Treatment  killing  1000 cells  and range  index 
thin 
None  60  51.6  12  (3-16)  3.4 
Puromycin*  60  52.6  7  (5-11)  3.4 
None  105  50.0  69  (64--76)  4.5 
Puromycin*  105  49.8  46  (40-54)  4.4 
* 2.5  mg of puromycin per  mouse given either  15 
min  or  15  and  75  min  after  a  single  injection  of 
25 #c of thymidine-H 3. 
into  phases  of  the  following  length:  Gt,  4.5  to 
5.5 hr;  S,  5  hr;  G~ and  mitosis,  less than  2  hr. 
If cells  are  labeled  with  thymidine-H  3  in  the 
S  phase  and  followed for various intervals there- 
after, the length of the G~ phase can be measured 
by  the  time  of  appearance  of  labeled  mitoses. 
If cells are delayed  in  the Ga phase,  the  appear- 
ance  of  labeled  mitoses  is  also  delayed.  If cells 
are  blocked  in  G~,  no  labeled  mitoses  are  seen. 
Similarly,  the mitotic  index can  be  used  to  indi- 
cate  the  presence  of  a  block  in  mitosis  or  G~. 
The mitotic index increases if ceils are blocked in 
mitosis  alone,  or  it  decreases  if  the  cells  are 
blocked in G~.  Table  III shows an experiment in 
which  crypt  cells  prelabeled  with  thymidine-H  3 
were  treated  with  puromycin  and  examined 
radioautographically  at  suitable  intervals.  The 
interval  between  labeling  and  killing  was  suffi- 
cient  to  allow some  labeled  cells to  pass  from  S 
through  G~ and  into  mitosis.  The experimentally 
determined  length of G2 was  1 hr,  which  agreed 
with  the  figures  given  by  other  authors  (23). 
The  percentage  of  labeled  mitoses  decreased  in 
puromycin-treated  animals,  indicating  that  a  G2 
delay  rather  than  a  block  was  produced  by  this 
dose  of  antibiotic.  The  mitotic  index  remained 
the  same,  indicating  that  puromycin  did  not 
produce  a  mitotic  block  but  that  both  G~  and 
mitoses were delayed. 
The data presented in Fig.  1 suggested that the 
cells were blocked  in  S  phase,  because  the onset 
of inhibition of DNA precursor  uptake  was rapid 
and  marked,  but  the possibility of a  concomitant 
Gx block  cannot  be  ruled  out  in  the  present  ex- 
perimental conditions. 
TABLE  IV 
Effects of Some Antibiotics or Antimetabolites on Incorporation of Precursors by the Small Intestine of Mice* 
Specific activity (Per cent of control) 
Agent 
DNA after thymidine-H3  RNA after cytidine-H~  Proteins after leueine-Ha  Per  cent 
necrosis  of 
30 rain  2  hr  4hr  1 hr  2  hr  4hr  30 min  2  hr  4  br  crypt  cell 
Actinomycin D  100  53  65  14  100  100  0 
Cytosine arabinoside  6  1  100  96  136  30 
Actidione  19  14  10  7  11  0 
Puromycin aminonucleoside  60  64  182  0 
* Actinomycin D : one injection of 50/~g per mouse.  Cytosine arabinoside : 4.5 mg per mouse. Actidione : 
10 mg per mouse and  puromycin  aminonucleoside: 2.5  mg per  mouse injected hourly  starting  at  zero 
time.  The total  time of each experiment from initial injection to killing is indicated  at the top of the 
Table for each isotope. Isotopes were injected subcutaneously  30 rain prior  to killing.  Each  figure repre- 
sents  at least 3 animals. 
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Other  compounds  were  used  to  establish 
whether  or  not  a  pattern  of  inhibition  of  pre- 
cursor uptake into DNA, RNA, or protein could 
be  related  to  the  production  of crypt  damage. 
Table IV shows  the  results of these  experiments. 
A  single injection of actinomycin D,  1.33 mg/kg, 
produced  90%  inhibition  of  cytidine-H  3  incor- 
poration into RNA in the small intestine. Thymi- 
dine-H  3  incorporation  into  DNA  was  inhibited 
50%  after  4  hr,  but  there  was  no  inhibition  of 
leucine-H  3 incorporation  into  protein.  However, 
crypt  cell  damage  did  not  appear  in  the  small 
intestine of mice even 8 hr after a  single injection 
of  actinomycin  D,  although  the  dose  used  was 
greater than the  1.0 mg/kg which Schwartz et al. 
(34)  found  produced  94%  inhibition  of  RNA 
synthesis  and  50%  inhibition  of DNA  synthesis, 
as  well as  cell damage,  in  regenerating rat  liver. 
Cytosine  arabinoside  promptly  inhibited  in- 
corporation  of  precursors  into  DNA  to  13%  of 
control values,  but  neither  leucine-H  a incorpora- 
tion  into  protein  nor  cytidine-H  3 incorporation 
into  RNA  was  inhibited.  In  fact,  leucine  incor- 
poration  was  above  control  levels at  2  hr.  This 
drug  produced  crypt cell damage which was not 
qualitatively different from  that  seen  with  puro- 
mycin. 
Actidione produced  93 %  inhibition of leucine 
incorporation  into  proteins,  85%  inhibition  of 
thymidine  incorporation  into  DNA,  and  a  90% 
inhibition  of  cytidine  incorporation  into  RNA. 
However,  no  crypt  cell damage  was  seen  in  the 
small intestine of mice 5 hr after the first injection 
of actidione. 
Puromycin  aminonucleoside  at  a  dose  of  2.5 
mg per mouse produced a 40 % inhibition of both 
thymidine  incorporation  into  DNA  and  uridine 
incorporation  into  RNA.  However,  leucine  in- 
corporation  into  protein  was  increased,  as  with 
cytosine  arabinoside.  No  cell  damage  was  seen 
in the crypts. 
Radioautographs of the tissues,  whose chemical 
analyses  are  given in  Table IV,  showed  that  the 
effect of the  antibiotics and  antimetabolites used 
in  these  experiments  was  roughly  of  the  same 
magnitude in the several components of the small 
intestine. The only exception was the effect on the 
incorporation  of  thymidine-H  3,  which  was,  of 
course, largely limited to the crypts.  Inhibition of 
cytidine-H  a  incorporation  by  actinomycin  D  or 
puromycin  aminonucleoside  affected  every  cell 
type.  Radioautographs  from  actidione-treated 
animals  gave  evidence  of  so  little  radioactivity 
that  no  quantitative  determination  was  at- 
tempted.  However,  this  observation  per  se  indi- 
cates  that  the  inhibitory effect extended  to  every 
cell type. 
DISCUSSION 
Puromycin inhibits protein synthesis  in vivo (14), 
and recent reports as well as our results show that 
it  also  inhibits  incorporation  of  thymidine  into 
DNA  and  incorporation  of  cytidine  or  uridine 
into  RNA in  vivo and  in  vitro  (15,  18, 24).  Our 
data  further  indicate  that  puromycin  blocks  the 
crypt cells of the small intestine in the S phase of 
the  cell cycle,  with  a  concomitant  but  slight  G~ 
and  mitotic  delay.  Kishimoto  and  Lieberman 
(21)  have  demonstrated,  in  cultures  of  kidney 
cells,  a  G2 delay or block, depending on the dose 
of  puromycin  used.  Studzinski  and  Love  (37) 
have  demonstrated  both  a  preprophase  block, 
interpreted as  a  G2 block, and mitotic arrest with 
varying doses  of puromycin.  The possibility of a 
G~  Mock,  concomitant  with  a  block  in  the  S 
phase, has not been ruled out.  To our knowledge, 
the  literature  contains  no  reports  of  necrosis  of 
cells after puromycin in vivo, although cell death 
in  puromycin-treated  tissue  cultures  has  been 
described  (22).  No effort has been  made in these 
experiments  to  ascertain  whether  the  decreased 
incorporation  of  precursors  reflected  a  true  de- 
crease in rate of macromolecular synthesis or was 
due to concomitant changes in other parameters, 
such  as  the  size  of the  endogenous  pool  of pre- 
cursors.  However,  it  should  be  noted  that  the 
inhibitory  action  has  already  been  studied  in 
detail for most of the compounds used in these ex- 
periments.  Thus: (a)  the inhibitory effect of puro- 
mycin on  protein  synthesis  has  been  determined 
in a variety of living systems  (14-16),  while Stud- 
zinski and  Love (37)  have shown that  the amino 
acid  and  nucleotide  precursor  pools  are  not  af- 
fected  by  puromycin;  (b)  the  prompt  inhibitory 
effect of actinomycin D on RNA synthesis  and the 
delayed inhibitory effect on DNA synthesis  with- 
out concomitant changes in  precursor  pools have 
also  been  described  in  several  living systems  (4, 
27,  30);  (c)  the  inhibition  of DNA  synthesis  by 
cytosine  arabinoside  has  also  been  demonstrated 
unequivocally  (7);  and  (d)  the  generalized  in- 
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synthesis  has also  been reported  in the literature 
(6).  In addition, unpublished experiments in our 
laboratory,  with  p32  and  formate-C  14,  confirm 
the  inhibitory effects  of  puromycin and  actino- 
mycin D  on  nucleic acid  synthesis  in  the  small 
intestine.  The  only compound  whose  inhibitory 
effect has not been clearly ascertained is therefore 
the  aminonucleoside  of  puromycin,  although 
some evidence is available from bacterial studies 
(10).  It therefore seems reasonable to assume that, 
with  the  exception  of  the  aminonucleoside, de- 
creased  incorporation of  precursors  in  these  ex- 
periments can be taken to signify decreased macro- 
molecular synthesis. 
There  is  no  clear-cut  relationship  between 
suppression of precursor incorporation into DNA, 
RNA, or protein and necrosis  of cells.  Actidione 
produced  a  pattern  of  suppression of  precursor 
incorporation similar to  that  produced  by puro- 
mycin and yet caused no cell necrosis.  However, 
actidione inhibition of RNA  synthesis is  prompt 
and  dramatic,  whereas  puromycin inhibition of 
RNA synthesis  is delayed and does  not go  below 
50%  of control values.  It  is  possible  that  puro- 
mycin-induced necrosis  of cells  engaged in DNA 
replication may  be  another  instance of  "unbal- 
anced  growth"  (2,  32).  It  is  interesting to  note 
that hydroxyurea, a compound that was not avail- 
able  for  these  experiments,  has  been  recently 
reported  to  produce lethal damage of tissue  cul- 
ture cells in DNA synthesis  (36),  and necrosis  of 
intestinal epithelial cells  (quoted  by Schwartz  et 
al.,  reference  33).  Hydroxyurea has  been found 
to  be  a  potent inhibitor of DNA  synthesis  (39), 
although no  effects  have  been observed on  syn- 
thesis  of RNA  or  protein  (33,  39).  However,  if 
puromycin-induced necrosis  is  another  example 
of  "unbalanced  growth,"  it  remains  to  be  ex- 
plained why cytosine arabinoside is so much less 
effective  than  puromycin in  producing  necrosis 
of crypt cells. 
In  a  more  detailed  analysis of  the  rapid  fall 
in precursor incorporation into DNA, one should 
note  that  Rosenkranz  and  Bendich  (31)  have 
suggested  that  the  continued synthesis of  DNA 
is  dependent upon  the  continued presence  of  a 
protein. However, there is also evidence that both 
puromycin and  its aminonucleoside interfere di- 
rectly with the synthesis of purines (8,  10,  13,  19). 
It seems clear that dividing cells of puromycin- 
treated mice are severely injured. While requiring 
a  lag period  to  show  damage,  these  cells are  ir- 
reversibly injured, although the inhibitory action 
of puromycin on protein synthesis  is at least par- 
tially reversible  (9,  12). It  is  also  apparent that 
nondividing cells  show  no  similar damage.  The 
action of puromycin which results in damage to 
dividing cells  remains unknown. The  possibility 
of an increased uptake of puromycin by cells  in 
DNA  synthesis  is  not  supported  by  the  finding 
that protein synthesis  is equally inhibited in pro- 
liferating  and  nonproliferating tissues.  There  is 
room for a  reasonable doubt that the necrotizing 
effect of puromycin is not due to the effect on pro- 
tein synthesis  alone.  Since there  is evidence that 
puromycin  directly  affects  DNA  synthesis  and 
since  it  causes  necrosis  only  in  dividing  cells, 
one is tempted to speculate that this direct action 
is involved in the  mechanism responsible for  the 
necrosis  of  these  cells.  However,  other  factors, 
such  as  the  continued synthesis of other  macro- 
molecules, must be part of the complex sequence 
of events leading to cell death. 
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